Year Founded
1980
Ownership
Private
Employees
~1000
Therapeutic Areas
RheumatologyNeurologyOphthalmologyImmunology
Stage
Commercial
Modalities
Small moleculeMedical devices

TRB Chemedica General Information

Market-leading pharma company focused on rheumatology, ophthalmology and neurology with established commercial products. Key products include hyaluronic acid-based treatments.

Contact Information

Website
Primary Industry
Pharma
Corporate Office
Geneva,
Switzerland

Drug Pipeline

hyaluronic acid
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to TRB Chemedica's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

TRB Chemedica Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view TRB Chemedica's complete valuation and funding history, request access »